- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07737808
EFFECTIVENESS OF SOLUTION-FOCUSED APPROACH-BASED PSYCHOEDUCATION IN INDIVIDUALS DIAGNOSED WITH SUBSTANCE USE DISORDER: A RANDOMIZED CONTROLLED TRIAL
Substance use disorder (SUD) is a chronic, relapsing psychiatric disorder characterized by compulsive substance use despite harmful physical, psychological, and social consequences. It is associated with impaired psychosocial functioning, reduced self-efficacy, decreased psychological well-being, and a high risk of relapse. Although detoxification, pharmacotherapy, and routine psychoeducation constitute the standard components of treatment, many individuals continue to experience difficulties maintaining recovery after discharge. Therefore, there is an increasing need for psychosocial interventions that strengthen personal resources, promote recovery, and improve long-term treatment outcomes.
The Solution-Focused Approach (SFA) is a strengths-based therapeutic model that emphasizes individuals' existing resources, successful experiences, future goals, and problem-solving abilities rather than focusing on deficits and pathology. Instead of exploring the causes of substance use, SFA encourages individuals to identify exceptions to their problems, recognize previous successes, build hope, and develop practical solutions that support behavioral change. Previous studies have suggested that solution-focused interventions may improve self-efficacy, motivation for change, coping skills, psychological well-being, and treatment engagement. However, evidence regarding the effectiveness of structured solution-focused psychoeducation programs among individuals with substance use disorder remains limited, particularly in randomized controlled trials conducted in inpatient addiction treatment settings.
The purpose of this randomized controlled trial is to evaluate the effectiveness of a structured Solution-Focused Approach-based psychoeducation program on addiction profile, self-efficacy, and psychological well-being among individuals diagnosed with substance use disorder receiving inpatient treatment.
The study was conducted between February and August 2025 at the Adult Detoxification Center of a Mental Health and Neurological Diseases Training and Research Hospital in Istanbul, Türkiye. Following completion of the detoxification phase and confirmation of eligibility criteria, participants were randomly assigned to either an intervention group or a control group. A total of 60 participants completed the study, with 30 individuals allocated to each group.
Participants assigned to the intervention group received routine inpatient treatment in addition to a structured seven-session Solution-Focused Approach-based psychoeducation program developed by the researcher according to the principles of solution-focused therapy. Each session lasted approximately 60 to 90 minutes and was delivered twice weekly in small groups. The intervention included group orientation, identification of personal strengths and resources, goal setting, miracle questions, exception finding, scaling questions, solution-focused brainstorming, future-oriented planning, relapse prevention strategies, and termination activities. Throughout the intervention, participants were encouraged to identify successful coping experiences, develop realistic future goals, recognize their existing strengths, and enhance confidence in their ability to maintain recovery.
Participants in the control group received routine inpatient addiction treatment only. Routine treatment consisted of detoxification, pharmacotherapy, therapeutic milieu interventions, psychoeducation delivered through the national SAMBA program, physician follow-up, psychiatric nursing care, family meetings, and other standard clinical services provided by the treatment center.
Outcome assessments were performed before the intervention and immediately after completion of the psychoeducation program. Data were collected using the Addiction Profile Index (BAPI), the Self-Efficacy Scale, and the Psychological Well-Being Scale. Sociodemographic and clinical characteristics were also recorded.
The primary objective of this study was to determine whether solution-focused psychoeducation improves psychological well-being and self-efficacy compared with routine inpatient treatment alone. Secondary objectives included evaluating changes in addiction profile and its subdimensions, particularly craving and safe behavioral characteristics.
It was hypothesized that participants receiving the Solution-Focused Approach-based psychoeducation program would demonstrate greater improvements in psychological well-being and self-efficacy, together with reductions in craving and addiction-related problems, compared with participants receiving routine treatment alone. The findings of this study are expected to contribute to the development of evidence-based psychosocial nursing interventions for individuals with substance use disorder and to support the integration of recovery-oriented psychoeducation into routine addiction treatment services.
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Studietype
Registrering (Faktiske)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
bakırköy
-
Istanbul, bakırköy, Tyrkia (Türkiye), 340000
- Istanbul Bakirkoy Prof. Dr. Mazhar Osman Mental Health and Neurological Diseases Training and Research Hospital
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Voksen
- Eldre voksen
Tar imot friske frivillige
Beskrivelse
Inclusion Criteria:
- Being 18 years of age or older with a diagnosis of Alcohol and Substance Use Disorder and having completed detoxification at the Adult Detoxification Center, having completed an average of three days of hospitalization.
Exclusion Criteria:
- Those who want to withdraw from the study,
- Those whose clinical condition deteriorates, those who have onset of psychotic symptoms,
- Those who have verbal communication disorders,
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: N/A
- Intervensjonsmodell: Enkeltgruppeoppdrag
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: EFFECTS OF SOLUTION-FOCUSED APPROACH-BASED PSYCHOEDUCATION ON ADDICTION PROFILE, SELF-EFFICACY AND P
|
psychoeducation based on solution-focused approach
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Addiction Profile Index Clinical Form (BAPI-K) Total Score
Tidsramme: Baseline and immediately after completion of the 7-session psychoeducation program (approximately 4 weeks)
|
Change in addiction severity measured using the Addiction Profile Index Clinical Form (BAPI-K).
Higher scores indicate greater addiction severity.
The total score will be compared between baseline and post-intervention.
|
Baseline and immediately after completion of the 7-session psychoeducation program (approximately 4 weeks)
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Self-Efficacy Scale Total Score
Tidsramme: Baseline and immediately after the 7-session psychoeducation program (approximately 4 weeks)
|
Change in psychological well-being measured using the Psychological Well-Being Scale.
Total scores will be compared between baseline and immediately after completion of the intervention.
|
Baseline and immediately after the 7-session psychoeducation program (approximately 4 weeks)
|
Andre resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Psychological Well-Being Scale Total Score
Tidsramme: Baseline and immediately after the 7-session psychoeducation program (approximately 4 weeks)
|
Change in psychological well-being measured using the Psychological Well-Being Scale.
Total scores will be compared between baseline and immediately after completion of the intervention.
|
Baseline and immediately after the 7-session psychoeducation program (approximately 4 weeks)
|
Samarbeidspartnere og etterforskere
Sponsor
Publikasjoner og nyttige lenker
Generelle publikasjoner
- Abdollahi, Z., Taghizadeh, F., Hamzehgardeshi, Z., & Bahramzad, O. (2014). Relationship between Addiction Relapse and Self-Efficacy Rates in Injection Drug Users Referred to Maintenance Therapy Center of Sari, 1391. Global Journal of Health Science, 6(3), p138. https://doi.org/10.5539/gjhs.v6n3p138 Abram, M. D. (2018). The Role of the Registered Nurse Working in Substance Use Disorder Treatment: A Hermeneutic Study. Issues in Mental Health Nursing, 39(6), 490-498. https://doi.org/10.1080/01612840.2017.1413462 Achury-Saldaña, D., Duran De-Villalobos, M. M., & Fuentes-Ramirez, A. (2025). Self-Efficacy in People With Chronic Disease: An Evolutionary Concept Analysis. Nursing Open, 12(7), e70276. https://doi.org/10.1002/nop2.70276 Akın, A. (2008). Psikolojik İyi Olma Ölçekleri (PİOÖ): Geçerlik ve Güvenirlik Çalışması. 8(3). Ali M. (2018). Solution Focused Brief Therapy in Alcohol Dependence Syndrome [Master's Thesis]. ndia: Ranchi University Psychology Faculty, Department of Clinical Psychology. Anderson, H. (1997). Conversation, language and possibilities: A post-modern approach to therapy. APA (5th ed). (2013). American Psychiatric Publishing. Arias, A. R. L., Buss, D. F., Alburquerque, C. D., Inácio, A. F., Freire, M. M., Egler, M., Mugnai, R., & Baptista, D. F. (2007). Utilização de bioindicadores na avaliação de impacto e no monitoramento da contaminação de rios e córregos por agrotóxicos. Ciência & Saúde Coletiva, 12(1), 61-72. https://doi.org/10.1590/S1413-81232007000100011 Bagdasarian, F. A., Hansen, H. D., Chen, J., Yoo, C.-H., Placzek, M. S., Hooker, J. M., & Wey, H.-Y. (2024). Acute Effects of Hallucinogens on Functional Connectivity: Psilocybin and Salvinorin-A. ACS Chemical Neuroscience, 15(14), 2654-2661. https://doi.org/10.1021/acschemneuro.4c00245 Balster, R. L., Cruz, S. L., Howard, M. O., Dell, C. A., & Cottler, L. B. (2009). Classification of abused inhalants. Addiction, 104(6), 878-882. https://doi.org/10.1111/j.1360-0443.2008.02494.x Bandura, A. (1
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- OkanU-KO-1
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .